| Literature DB >> 35121598 |
Tom Bourne1,2, Christopher Kyriacou3, Harsha Shah3, Jolien Ceusters4, Jessica Preisler5,6, Ulrike Metzger7, Chiara Landolfo8, Christoph Lees9, Dirk Timmerman2,10.
Abstract
OBJECTIVE: Assess experience of healthcare professionals (HCPs) working with ultrasound in obstetrics and gynaecology during the evolving SARS-CoV-2 pandemic, given the new and unprecedented challenges involving viral exposure, personal protective equipment (PPE) and well-being.Entities:
Keywords: gynaecology; public health; ultrasonography; ultrasound
Mesh:
Year: 2022 PMID: 35121598 PMCID: PMC8819548 DOI: 10.1136/bmjopen-2021-051700
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Demographics of total survey participation (N=3237)
| Total (N=3237) | |
| Total ISUOG mailing list (n) | 35 509 |
| Response of total ISUOG mailing list, N (%) | 3237 (9) |
| Countries (n) | 124 |
| Respondents in English (n) | 1960 |
| Respondents in Spanish (n) | 881 |
| Respondents in Italian (n) | 267 |
| Respondents in French (n) | 129 |
| ISUOG members, n (%) | 2441 (23) |
| Completed survey, n (%) | 2237 (69) |
| ISUOG members, n (%) | 1795 (80) |
| Countries (n) | 115 |
| Age (years), mean (range) | 47.2 (18–82) |
| ≤20, n (%) | 1 (0) |
| 21–30, n (%) | 117 (5) |
| 31–40, n (%) | 558 (25) |
| 41–50, n (%) | 686 (31) |
| 51–60, n (%) | 596 (27) |
| 61–70, n (%) | 251 (11) |
| >70, n (%) | 24 (1) |
| Gender, n (%) | |
| Female | 1474 (66) |
| Male | 755 (34) |
| Intersex | 1 (0) |
| Prefer not to say | 3 (0) |
| Prevalence suspected/confirmed SARS-CoV-2 based on symptoms±PCR testing, n (%) | 290 (13) |
| Is PPE used by the respondents? n (%) | |
| Not yet | 279 (12) |
| Yes—for aerosol-generating procedures only | 133 (6) |
| Yes—for all patients | 1392 (62) |
| Yes—for suspected/positive patients only | 429 (19) |
| What PPE is used by the respondents? n (%) | |
| None | 76 (3) |
| Gloves only | 49 (2) |
| Gloves+surgical mask | 497 (22) |
| Gloves+surgical mask+visor | 152 (7) |
| Gloves+FFP3 mask | 95 (4) |
| Gloves+FFP3 mask+visor | 51 (2) |
| Gloves+FFP3 mask+visor+gown+surgical hat | 90 (4) |
| Patient wearing mask | 1841 (82) |
| Concerns regarding a lack of PPE, n (%) | |
| No | 579 (26) |
| Gloves | 278 (12) |
| Gown | 629 (28) |
| N95/FFP3 mask | 1279 (57) |
| Surgical hat | 233 (10) |
| Surgical mask | 820 (37) |
| Visor | 582 (26) |
| Surgical mask (patient) | 609 (27) |
| Type of PPE that has been reused or recycled, n (%) | |
| No | 865 (39) |
| Gloves | 34 (2) |
| Gown | 287 (13) |
| N95/FFP3 mask | 886 (40) |
| Surgical hat | 92 (4) |
| Surgical mask | 565 (25) |
| Visor | 621 (28) |
| Anxiety, mean (95% CI)* | 6.9 (6.7 to 7.2) |
| 0–7 (none), n (%) | 620 (59) |
| 8–10 (mild), n (%) | 229 (22) |
| 11–21 (moderate to severe), n (%) | 209 (20) |
| Depression, mean (95% CI)* | 5.3 (5.1 to 5.5) |
| 0–7 (none), n (%) | 760 (72) |
| 8–10 (mild), n (%) | 205 (19) |
| 11–21 (moderate to severe), n (%) | 93 (9) |
*Numbers of Hospital and Anxiety Depression Scale (HADS) respondents lower than the main survey (n=1058).
ISUOG, International Society of Ultrasound in Obstetrics and Gynecology; PCR, Polymerase Chain Reaction; PPE, personal protective equipment.
Breakdown of findings by country (N=2233)
| Italy | Spain | India | Philippines | UK | USA | Other* | |
| Respondents, n (%) | 174 (8) | 136 (6) | 115 (5) | 114 (5%) | 103 (5) | 102 (5) | 1489 (67) |
| Prevalence of suspected/confirmed SARS-CoV-2 based on symptoms±PCR testing, n (%) | 26 (15) | 20 (15) | 3 (3) | 10 (9) | 32 (31) | 14 (14) | 185 (12) |
| Had SARS-CoV-2 antibody test, n (%) | 92 (53) | 82 (60) | 1 (1) | 21 (18) | 1 (1) | 16 (16) | 155 (10) |
| Had positive SARS-CoV-2 antibody, n (%) | 6 (7) | 11 (13) | 0 (0) | 0 (0) | 0 (0) | 4 (25) | 16 (10) |
| Is PPE used by the respondents? n (%) | |||||||
| 17 (10) | 28 (21) | 31 (27) | 6 (5) | 7 (7) | 5 (5) | 185 (12) | |
| 8 (5) | 6 (4) | 9 (8) | 7 (6) | 6 (6) | 3 (3) | 94 (6) | |
| 107 (61) | 33 (24) | 65 (57) | 96 (84) | 76 (74) | 83 (81) | 932 (63) | |
| 42 (24) | 69 (51) | 10 (9) | 5 (4) | 14 (14) | 11 (11) | 278 (19) | |
| What PPE is used by the respondents? n (%) | |||||||
| 0 (0) | 1 (1) | 1 (1) | 1 (1) | 1 (1) | 0 (0) | 72 (5) | |
| 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (2) | 0 (0) | 47 (3) | |
| 79 (45) | 42 (31) | 7 (6) | 0 (0) | 41 (40) | 45 (44) | 283 (19) | |
| 6 (3) | 11 (8) | 6 (5) | 1 (1) | 17 (17) | 12 (12) | 99 (7) | |
| 12 (7) | 10 (7) | 8 (7) | 0 (0) | 0 (0) | 6 (6) | 59 (4) | |
| 1 (1) | 4 (3) | 6 (5) | 2 (2) | 0 (0) | 3 (3) | 35 (2) | |
| 3 (2) | 5 (4) | 13 (11) | 23 (20) | 0 (0) | 1 (1) | 45 (3) | |
| 173 (99) | 133 (98) | 109 (95) | 111 (97) | 33 (32) | 91 (89) | 1191 (80) | |
| Concerns regarding a lack of PPE, n (%) | |||||||
| No | 35 (20) | 14 (10) | 52 (45) | 20 (18) | 46 (45) | 24 (24) | 388 (26) |
| Gloves | 25 (14) | 19 (14) | 5 (4) | 12 (11) | 1 (1) | 9 (9) | 207 (14) |
| Gown | 53 (30) | 45 (33) | 23 (20) | 54 (47) | 25 (24) | 23 (23) | 406 (27) |
| N95/FFP3 mask | 118 (68) | 110 (81) | 51 (44) | 84 (74) | 33 (32) | 61 (60) | 822 (55) |
| Surgical hat | 15 (9) | 10 (7) | 10 (9) | 15 (13) | 4 (4) | 8 (8) | 171 (11) |
| Surgical mask | 84 (48) | 62 (46) | 10 (9) | 21 (18) | 24 (23) | 45 (44) | 574 (39) |
| Visor | 51 (29) | 51 (38) | 11 (10) | 19 (17) | 19 (18) | 24 (24) | 407 (27) |
| Surgical mask (patient) | 44 (25) | 47 (35) | 10 (9) | 32 (28) | 13 (13) | 31 (30) | 432 (29) |
| Type of PPE that has been reused or recycled, n (%) | |||||||
| No | 55 (32) | 31 (23) | 40 (35) | 25 (22) | 62 (60) | 12 (12) | 640 (43) |
| Gloves | 2 (1) | 3 (2) | 5 (4) | 2 (2) | 0 (0) | 1 (1) | 21 (1) |
| Gown | 15 (9) | 17 (13) | 23 (20) | 70 (61) | 3 (3) | 4 (4) | 155 (10) |
| N95/FFP3 mask | 82 (47) | 82 (60) | 59 (51) | 66 (58) | 10 (10) | 68 (67) | 519 (35) |
| Surgical hat | 2 (1) | 7 (5) | 1 (1) | 16 (14) | 1 (1) | 4 (4) | 61 (4) |
| Surgical mask | 83 (48) | 60 (44) | 7 (6) | 13 (11) | 14 (14) | 65 (64) | 323 (22) |
| Visor | 23 (13) | 48 (35) | 31 (27) | 56 (49) | 28 (27) | 28 (27) | 407 (27) |
| Mean days of self-isolation (range) | 11.3 | 11.6 | 17.3 | 16.9 | 8.8 | 8.8 | 8.4 |
| Mean days of household self-isolating (range) | 21.1 (14–30) | 10.5 (2–15) | 18 (10–30) | 15.3 (7–30) | 11.1 (2–14) | 15 (2–30) | 12.2 (1–30) |
| Respondents satisfied with local unit SARS-CoV-2 response, n (%) | 89 (51) | 97 (71) | 89 (77) | 89 (78) | 75 (73) | 74 (73) | 1018 (68) |
| Mean % level of respondent satisfaction with government SARS-CoV-2 response (95% CI) | 38 (34 to 41) | 23 (19 to 26) | 61 (56 to 65) | 48 (44 to 52) | 43 (38 to 48) | 37 (31 to 43) | 53 (52 to 55) |
| Anxiety, mean (95% CI)† | 6.3 | 6.9 | 7.4 | 7.1 | 7.2 | 7.3 | 6.9 |
| 0–7 (none), n (%) | 74 (71) | 51 (61) | 22 (51) | 18 (50) | 36 (58) | 35 (59) | 384 (57) |
| 8–10 (mild), n (%) | 13 (12) | 21 (25) | 13 (30) | 10 (28) | 12 (19) | 8 (14) | 152 (23) |
| 11–21 (moderate to severe), n (%) | 17 (16) | 12 (14) | 8 (19) | 8 (22) | 14 (23) | 16 (27) | 134 (20) |
| Depression, mean (95% CI)† | 5.8 | 5 | 5.1 | 5.3 | 5.3 | 4.8 | 5.3 |
| 0–7 (none), n (%) | 74 (71) | 67 (80) | 31 (72) | 27 (75) | 44 (71) | 46 (78) | 471 (70) |
| 8–10 (mild), n (%) | 20 (19) | 11 (13) | 10 (23) | 8 (22) | 12 (19) | 9 (15) | 135 (20) |
| 11–21 (moderate to severe), n (%) | 10 (10) | 6 (7) | 2 (5) | 1 (3) | 6 (10) | 4 (7) | 64 (10) |
*The 1489 within the ‘other’ cohort make up data from participants of the remaining 109 countries. We provide a breakdown of the six countries that had the most respondents.
†Numbers of Hospital and Anxiety Depression Scale (HADS) respondents lower than the main survey (n, Italy=104; Spain=84; India=43; Philippines=36; UK=62; USA=59; Other=670).
PCR, Polymerase Chain Reaction; PPE, personal protective equipment.
Breakdown of findings by HCP (N=2233)
| Consultants/attending | Sonographer | Trainees/residents | |
| Respondents, n (%) | 1480 (66) | 499 (22) | 254 (11) |
| Changes in shift pattern as a result of the pandemic, n (%) | |||
| Unable to work | 34 (2) | 21 (4) | 11 (4) |
| Change in duties due to SARS-CoV-2 pandemic, n (%) | |||
| Increased work | 185 (13%) | 64 (13%) | 37 (15%) |
| Similar work | 570 (39%) | 228 (46%) | 82 (32%) |
| Decreased work | 691 (47%) | 186 (37%) | 124 (49%) |
| Change in patient contact due to the SARS-CoV-2 pandemic, n (%) | |||
| Increased patient contact | 114 (8) | 35 (7) | 22 (9) |
| Similar patient contact | 530 (36) | 212 (42) | 90 (35) |
| Decreased patient contact | 743 (50) | 214 (43) | 119 (47) |
| No patient contact | 59 (4) | 17 (3) | 12 (5) |
| Level of COVID-19 risk of working environment reported by HCPs, n (%) | |||
| High risk of COVID-19 infection | 1144 (77%) | 337 (68%) | 221 (87%) |
| Moderate risk of COVID-19 infection | 128 (9%) | 32 (6%) | 14 (6%) |
| Low risk of COVID-19 infection | 208 (14%) | 130 (26%) | 19 (7%) |
| Interaction with patients with suspected/confirmed SARS-CoV-2, n (%) | 601 (41%) | 121 (24%) | 145 (57%) |
| Is PPE used by the respondents? n (%) | |||
| Not yet | 171 (12) | 75 (15) | 33 (13) |
| Yes—for aerosol-generating procedures only | 89 (6) | 28 (6) | 16 (6) |
| Yes—for all patients | 934 (63) | 334 (67) | 124 (49) |
| Yes—for suspected/positive patients only | 286 (19) | 62 (12) | 81 (32) |
| What PPE is used by the respondents? n (%) | |||
| None | 47 (3) | 21 (4) | 8 (3) |
| Gloves only | 20 (1) | 25 (5) | 4 (2) |
| Gloves+surgical mask | 315 (21) | 105 (21) | 77 (30) |
| Gloves+surgical mask+visor | 111 (8) | 35 (7) | 6 (2) |
| Gloves+FFP3 mask | 70 (5) | 13 (3) | 12 (5) |
| Gloves+FFP3 mask+visor | 41 (3) | 8 (2) | 2 (1) |
| Gloves+FFP3 mask+visor+gown+surgical hat | 59 (4) | 24 (5) | 7 (3) |
| Patient wearing mask | 1274 (86) | 333 (67) | 234 (92) |
| Concerns regarding a lack of PPE, n (%) | |||
| No | 398 (27) | 140 (28) | 41 (16) |
| Gloves | 176 (12 | 63 (13) | 39 (15) |
| Gown | 403 (27) | 133 (27) | 93 (37) |
| N95/FFP3 mask | 860 (58) | 239 (48) | 180 (71) |
| Surgical hat | 142 (10) | 61 (12) | 30 (12) |
| Surgical mask | 516 (35) | 189 (38) | 115 (45) |
| Visor | 379 (26) | 122 (24) | 81 (32) |
| Surgical mask (patient) | 395 (27) | 133 (27) | 81 (32) |
| Type of PPE that has been reused or recycled, n (%) | |||
| No | 594 (40) | 205 (41) | 66 (26) |
| Gloves | 22 (1) | 9 (2) | 3 (1) |
| Gown | 166 (11) | 92 (18) | 29 (11) |
| N95/FFP3 mask | 596 (40) | 152 (30) | 138 (54) |
| Surgical hat | 59 (4) | 22 (4) | 11 (4) |
| Surgical mask | 357 (24) | 116 (23) | 92 (36) |
| Visor | 401 (27) | 138 (28) | 82 (32) |
| Prevalence of suspected/confirmed SARS-CoV-2-based on symptoms±PCR testing, n (%) | 187 (13) | 71 (14) | 32 (13) |
| Had SARS-CoV-2 antibody test, n (%) | 259 (18) | 55 (11) | 54 (21) |
| Had positive SARS-CoV-2 antibody, n (%) | 28 (11) | 5 (9) | 4 (7) |
| Mean days of self-isolation (range) | 9.6 (0–30) | 9.7 (0–30) | 8.5 (0–30) |
| Mean days of household self-isolating (range) | 13 (1–30) | 14.3 (2–30) | 8.8 (2–14) |
| Respondents satisfied with local unit SARS-CoV-2 response, n (%) | 1043 (70) | 340 (68) | 148 (58) |
| Mean % level of respondent satisfaction with government SARS-CoV-2 response (95% CI) | 47 (46 to 49) | 57 (54 to 59) | 44 (40 to 47) |
| Anxiety, mean (95% CI)* | 6.7 (6.4 to 7.0) | 7.7 (7.1 to 8.3) | 6.9 (6.3 to 7.6) |
| 0–7 (none), n (%) | 433 (61) | 112 (52) | 75 (58) |
| 8–10 (mild), n (%) | 151 (21) | 48 (22) | 30 (23) |
| 11–21 (moderate to severe), n (%) | 131 (18) | 54 (25) | 24 (19) |
| Depression, mean (95% CI)* | 5.3 (5.0 to 5.5) | 5.5 (5.0 to 6.1) | 5.3 (4.7 to 5.9) |
| 0–7 (none), n (%) | 523 (73) | 148 (69) | 89 (69) |
| 8–10 (mild), n (%) | 126 (18) | 50 (23) | 29 (22) |
| 11–21 (moderate to severe), n (%) | 66 (9) | 16 (7) | 11 (9) |
*Numbers of Hospital and Anxiety Depression Scale (HADS) respondents lower than the main survey (n, Consultants/attending=715; Sonographer=214; Trainees/residents=129).
HCP, healthcare professional; PCR, Polymerase Chain Reaction; PPE, personal protective equipment.
Breakdown of findings by combinations of PPE (N=2233)*
| None | Gloves only | Gloves+surgical mask | Gloves | Gloves | Gloves | Gloves | |
| Respondents (n, %) | 76 (3) | 49 (2) | 497 (22) | 152 (7) | 95 (4) | 51 (2) | 90 (4) |
| Level of COVID-19 risk of working environment reported, n (%) | |||||||
| High risk of COVID-19 infection | 50 (66) | 34 (69) | 394 (79) | 104 (68) | 60 (63) | 37 (73) | 73 (81) |
| Moderate risk of COVID-19 infection | 9 (12) | 3 (6) | 38 (8) | 16 (11) | 7 (7) | 6 (12) | 6 (7) |
| Low risk of COVID-19 infection | 17 (22) | 12 (24) | 65 (13) | 32 (21) | 28 (29) | 8 (16) | 11 (12) |
| Interaction with patients with suspected/confirmed SARS-CoV-2, n (%) | 22 (29) | 16 (33) | 226 (45) | 47 (31) | 31 (33) | 15 (29) | 34 (38) |
| Prevalence of suspected/confirmed SARS-CoV-2 based on symptoms±PCR testing, n (%) | 10 (13) | 14 (29) | 84 (17) | 17 (11) | 10 (11) | 2 (4) | 6 (7) |
| Respondents satisfied with local unit SARS-CoV-2 response, n (%) | 57 (75) | 33 (67) | 326 (66) | 112 (74) | 65 (68) | 38 (75) | 60 (67) |
| Mean % level of respondent satisfaction with government SARS-CoV-2 response (95% CI) | 63 (56 to 69) | 68 (60 to 76) | 50 (47 to 52) | 48 (43 to 53) | 42 (36 to 48) | 40 (32 to 47) | 47 (41 to 53) |
*All possible combinations are not included in this table; therefore, the denominator of the table is not 2233 (n=1010). Main relevant PPE combinations are described.
PCR, Polymerase Chain Reaction; PPE, personal protective equipment.